BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37696386)

  • 21. Receptor for advanced glycation end products: a key molecule in the genesis of chronic kidney disease vascular calcification and a potential modulator of sodium phosphate co-transporter PIT-1 expression.
    Belmokhtar K; Ortillon J; Jaisson S; Massy ZA; Boulagnon Rombi C; Doué M; Maurice P; Fritz G; Gillery P; Schmidt AM; Rieu P; Touré F
    Nephrol Dial Transplant; 2019 Dec; 34(12):2018-2030. PubMed ID: 30778553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of CtBP family protein isoforms in breast cancer and their role in chemoresistance.
    Birts CN; Harding R; Soosaipillai G; Halder T; Azim-Araghi A; Darley M; Cutress RI; Bateman AC; Blaydes JP
    Biol Cell; 2010 Jan; 103(1):1-19. PubMed ID: 20964627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevation of hsa-miR-7-5p level mediated by CtBP1-p300-AP1 complex targets ATXN1 to trigger NF-κB-dependent inflammation response.
    Lou LQ; Zhou WQ; Song X; Chen Z
    J Mol Med (Berl); 2023 Mar; 101(3):223-235. PubMed ID: 36629882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential contribution of possible pattern-recognition receptors to advanced glycation end product-induced cellular responses in macrophage-like RAW264.7 cells.
    Watanabe M; Toyomura T; Wake H; Liu K; Teshigawara K; Takahashi H; Nishibori M; Mori S
    Biotechnol Appl Biochem; 2020 Mar; 67(2):265-272. PubMed ID: 31654427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Receptors of Advanced Glycation End Product (RAGE) Suppression Associated With a Preserved Osteogenic Differentiation in Patients With Prediabetes.
    Phimphilai M; Pothacharoen P; Chattipakorn N; Kongtawelert P
    Front Endocrinol (Lausanne); 2022; 13():799872. PubMed ID: 35237235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. JNK and ATF4 as two important platforms for tumor necrosis factor-α-stimulated shedding of receptor for advanced glycation end products.
    Miyoshi A; Koyama S; Sasagawa-Monden M; Kadoya M; Konishi K; Shoji T; Inaba M; Yamamoto Y; Koyama H
    FASEB J; 2019 Mar; 33(3):3575-3589. PubMed ID: 30452882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fructose causes endothelial cell damage via activation of advanced glycation end products-receptor system.
    Sotokawauchi A; Matsui T; Higashimoto Y; Yamagishi SI
    Diab Vasc Dis Res; 2019 Nov; 16(6):556-561. PubMed ID: 31375034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease.
    Reynaert NL; Gopal P; Rutten EPA; Wouters EFM; Schalkwijk CG
    Int J Biochem Cell Biol; 2016 Dec; 81(Pt B):403-418. PubMed ID: 27373680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advanced glycation end-products induce heparanase expression in endothelial cells by the receptor for advanced glycation end products and through activation of the FOXO4 transcription factor.
    An XF; Zhou L; Jiang PJ; Yan M; Huang YJ; Zhang SN; Niu YF; Ten SC; Yu JY
    Mol Cell Biochem; 2011 Aug; 354(1-2):47-55. PubMed ID: 21461610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of advanced glycation endproducts formation by lotus seedpod oligomeric procyanidins through RAGE-MAPK signaling and NF-κB activation in high-AGEs-diet mice.
    Wu Q; Feng Y; Ouyang Y; Liang Y; Zhao K; Wang Y; Luo Q; Xiao J; Feng N; Zhou M
    Food Chem Toxicol; 2021 Oct; 156():112481. PubMed ID: 34375722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age-related accumulation of advanced glycation end-products-albumin, S100β, and the expressions of advanced glycation end product receptor differ in visceral and subcutaneous fat.
    Son KH; Son M; Ahn H; Oh S; Yum Y; Choi CH; Park KY; Byun K
    Biochem Biophys Res Commun; 2016 Aug; 477(2):271-6. PubMed ID: 27301641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The receptor for advanced glycation end-products enhances lung epithelial wound repair: An in vitro study.
    Zhai R; Blondonnet R; Ebrahimi E; Belville C; Audard J; Gross C; Choltus H; Henrioux F; Constantin JM; Pereira B; Blanchon L; Sapin V; Jabaudon M
    Exp Cell Res; 2020 Jun; 391(2):112030. PubMed ID: 32330509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mdia1 is Crucial for Advanced Glycation End Product-Induced Endothelial Hyperpermeability.
    Zhou X; Weng J; Xu J; Xu Q; Wang W; Zhang W; Huang Q; Guo X
    Cell Physiol Biochem; 2018; 45(4):1717-1730. PubMed ID: 29490301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Advanced Glycation End Products on Differentiation and Function of Osteoblasts and Osteoclasts.
    Park SY; Choi KH; Jun JE; Chung HY
    J Korean Med Sci; 2021 Sep; 36(37):e239. PubMed ID: 34581519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advanced glycation end products induce immature angiogenesis in in vivo and ex vivo mouse models.
    Chen L; Cui Y; Li B; Weng J; Wang W; Zhang S; Huang X; Guo X; Huang Q
    Am J Physiol Heart Circ Physiol; 2020 Mar; 318(3):H519-H533. PubMed ID: 31922896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteomeles schwerinae extracts inhibits the binding to receptors of advanced glycation end products and TGF-β1 expression in mesangial cells under diabetic conditions.
    Kim YS; Jung DH; Lee IS; Pyun BJ; Kim JS
    Phytomedicine; 2016 Apr; 23(4):388-97. PubMed ID: 27002409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advanced glycation end-products and receptor for advanced glycation end-products expression in patients with idiopathic pulmonary fibrosis and NSIP.
    Kyung SY; Byun KH; Yoon JY; Kim YJ; Lee SP; Park JW; Lee BH; Park JS; Jang AS; Park CS; Jeong SH
    Int J Clin Exp Pathol; 2014; 7(1):221-8. PubMed ID: 24427342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence that methylglyoxal and receptor for advanced glycation end products are implicated in bladder dysfunction of obese diabetic
    Oliveira AL; Medeiros ML; Ghezzi AC; Dos Santos GA; Mello GC; Mónica FZ; Antunes E
    Am J Physiol Renal Physiol; 2023 Oct; 325(4):F436-F447. PubMed ID: 37560771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A role for advanced glycation end products in diminished bone healing in type 1 diabetes.
    Santana RB; Xu L; Chase HB; Amar S; Graves DT; Trackman PC
    Diabetes; 2003 Jun; 52(6):1502-10. PubMed ID: 12765963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advanced Glycation End Products (AGEs), Glutathione and Breast Cancer: Factors, Mechanism and Therapeutic Interventions.
    Sharma AK; Sharma VR; Gupta GK; Ashraf GM; Kamal MA
    Curr Drug Metab; 2019; 20(1):65-71. PubMed ID: 30207227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.